Hema Now: Innovation and Impact in Lymphoma Care

In this episode of Hema Now, we speak with Cecilia Karlström about advances in rare and complex haematological disorders. She discusses the evolving understanding of platelet refractoriness and transfusion support, the challenges in diagnosing systemic mastocytosis, and how targeted therapies are reshaping outcomes in rare blood diseases. The conversation also explores the growing role of precision medicine, multidisciplinary care, and future priorities in haematology research.  Timestamps:     00:00 – Introduction     01:21 – Career inspiration in haematology origins   02:43 – Evolution of platelet refractoriness management   03:39 – Current state systemic mastocytosis care   05:03 – Diagnosing systemic mastocytosis challenges today   07;26 – Impact of targeted therapies mastocytosis   07:26 – Future precision medicine opportunities haematology   09:00 – Multidisciplinary care improving patient outcomes   10:25 – Improving equity rare disease access   11:43 – Exciting research areas haematological disorders   13:14 – Three wishes future haematology advances